Chotruangnapa Chavalit, Tansakun Titima, Roubsanthisuk Weranuj
Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Siriraj, Bangkoknoi, Bangkok, 10700, Thailand.
Clin Hypertens. 2021 Nov 15;27(1):22. doi: 10.1186/s40885-021-00180-4.
Night-time BP, especially non-dipper, is a stronger predictor of adverse cardiovascular outcomes. Ambulatory blood pressure monitoring (ABPM) is a gold standard for the detection of non-dippers but it often is unavailable and expensive. This study aims to determine clinical risk factors that predict non-dipper.
An exploratory traditional case-control study, exclusive sampling of control was conducted from January 2013 to September 2018 to explore clinical risk factors associated with non-dippers in hypertensive patients. Subgroup analysis was performed in each treated and untreated hypertensive patient. The parsimonious predictive score for non-dippers was constructed.
The study included 208 hypertensive patients receiving 24 h ABPM. There were 104 dippers and 104 non-dippers. Significant clinical risk factors associated with non-dippers were the age of > 65 years, average office diastolic blood pressure (DBP), and fasting plasma glucose of > 5.6 mmol/L. Results of subgroup analysis showed that dyslipidemia, history of coronary artery disease, use of angiotensin-converting enzyme inhibitors (ACEIs) and direct vasodilators, average office DBP, and serum uric acid were associated with non-dippers in treated hypertensive patients, however, there were no risk factors associated with non-dippers in the untreated group. The predictive score for non-dippers in treated group included average office DBP, dyslipidemia, serum uric acid, male, calcium channel blockers and ACEIs use. The area under Receiver Operating Characteristic (AuROC) was 0.723. A cut-off point which was > 0.0701 and prevalence of non-dippers of 46%, this score had a sensitivity of 77.4%, specificity of 65.6%, positive predictive value (PPV) of 66.1%, and negative predictive value (NPV) of 79.6%. For untreated group, age, hemoglobin and body mass index were included in the predictive model. AuROC was 0.74. There was a sensitivity of 51.9%, specificity of 91.2%, PPV of 82.4%, and NPV of 70.5% at the cut-off point of > 0.357, and prevalence of 44%.
There were several significant clinical risk factors associated with non-dippers in treated hypertensive patients. The predictive score might be useful for the detection of non-dippers; however, it cannot replace ABPM.
夜间血压,尤其是非勺型血压,是心血管不良结局的更强预测指标。动态血压监测(ABPM)是检测非勺型血压的金标准,但它往往难以获得且费用高昂。本研究旨在确定预测非勺型血压的临床风险因素。
2013年1月至2018年9月进行了一项探索性传统病例对照研究,采用对照的独家抽样方法,以探索高血压患者中与非勺型血压相关的临床风险因素。对每例接受治疗和未接受治疗的高血压患者进行亚组分析。构建非勺型血压的简约预测评分。
该研究纳入了208例接受24小时ABPM的高血压患者。其中有104例勺型血压者和104例非勺型血压者。与非勺型血压相关的显著临床风险因素为年龄>65岁、诊室平均舒张压(DBP)以及空腹血糖>5.6 mmol/L。亚组分析结果显示,血脂异常、冠状动脉疾病史、使用血管紧张素转换酶抑制剂(ACEIs)和直接血管扩张剂、诊室平均DBP以及血清尿酸与接受治疗的高血压患者中的非勺型血压相关,然而,未治疗组中没有与非勺型血压相关的风险因素。治疗组中非勺型血压的预测评分包括诊室平均DBP、血脂异常、血清尿酸、男性、使用钙通道阻滞剂和ACEIs。受试者操作特征曲线下面积(AuROC)为0.723。在截断点>0.0701且非勺型血压患病率为46%时,该评分的敏感性为77.4%,特异性为65.6%,阳性预测值(PPV)为66.1%,阴性预测值(NPV)为79.6%。对于未治疗组,预测模型纳入了年龄、血红蛋白和体重指数。AuROC为0.74。在截断点>0.357且患病率为44%时,敏感性为51.9%,特异性为91.2%,PPV为82.4%,NPV为70.5%。
接受治疗的高血压患者中存在几个与非勺型血压相关的显著临床风险因素。预测评分可能有助于检测非勺型血压;然而,它不能替代ABPM。